SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 31 | 29 | −2 |
| Shares | 1.55M | 1.90M | +344.7K (+22.2%) |
| Value | $13.3M | $21.3M | +$8.03M (+60.6%) |
New holders (5)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 109,282 | $1.43M | 0.00% |
| State Street Corp | 37,468 | $416.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 32,114 | $356.0K | 0.00% |
| JPMorgan Chase & Co | 876 | $10.0K | 0.00% |
| Royal Bank of Canada | 400 | $4.00K | 0.00% |
Sold out (7)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Nomura Holdings Inc | 131,500 | $1.11M |
| Ikarian Capital, LLC | 48,053 | $410.0K |
| Group One Trading, L.P. | 27,237 | $233.0K |
| Virtu Financial LLC | 14,593 | $125.0K |
| Bank of America Corp | 400 | $3.00K |
| Sowell Financial Services LLC | 10 | $0 |
| Core Wealth Advisors, Inc. | 30 | $0 |